Works about DRUG approval
Results: 5000
UroPipeline.
- Published in:
- Urology Times, 2025, v. 53, n. 2, p. 24
- By:
- Publication type:
- Article
Ebronucimab: First Approval: Ebronucimab: First Approval: H. A. Blair.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 437, doi. 10.1007/s40265-025-02146-4
- By:
- Publication type:
- Article
Risperidone In Situ Microparticles: A Review in Schizophrenia: Risperidone In Situ Microparticles: Y. Y. Syed.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 425, doi. 10.1007/s40265-024-02140-2
- By:
- Publication type:
- Article
Rezafungin: A Review in Invasive Candidiasis: Rezafungin: A Review: S. Fung, M. Shirley.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 415, doi. 10.1007/s40265-024-02134-0
- By:
- Publication type:
- Article
Recent and anticipated novel drug approvals (4Q 2024 through 3Q 2025).
- Published in:
- American Journal of Health-System Pharmacy, 2025, v. 82, n. 6, p. 291, doi. 10.1093/ajhp/zxae352
- By:
- Publication type:
- Article
Expert Discussion: ESMO 2024.
- Published in:
- 2025
- By:
- Publication type:
- Conference Paper/Materials
FDA-Approved Drugs to Treat ADHD.
- Published in:
- Journal of Psychosocial Nursing & Mental Health Services, 2025, v. 63, n. 3, p. 5, doi. 10.3928/02793695-20250128-79
- Publication type:
- Article
Identification and Management of CKD-Associated Pruritus: Current Insights.
- Published in:
- International Journal of Nephrology & Renovascular Disease, 2024, v. 17, p. 339, doi. 10.2147/IJNRD.S499798
- By:
- Publication type:
- Article
The Real-World Data Challenges Radar: A Review on the Challenges and Risks regarding the Use of Real-World Data.
- Published in:
- Digital Biomarkers, 2021, v. 5, n. 2, p. 148, doi. 10.1159/000516178
- By:
- Publication type:
- Article
Sotorasib Combo Bests Chemo Leading to Approval in KRAS G12C+ CRC.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 85
- By:
- Publication type:
- Article
FDA Approves Combination Regimen for Metastatic Colorectal Cancer.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 16
- By:
- Publication type:
- Article
FDA Approves Ionis' Tryngolza as First Treatment for Familial Chylomicronemia Syndrome.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 14
- Publication type:
- Article
FDA Approves Yesintek, Sixth Stelara Biosimilar; Launch Slated for February.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 24
- Publication type:
- Article
BCS-BASED BIOWAIVER MONOGRAPH FOR HYDROCHLOROTHIAZIDE.
- Published in:
- WHO Drug Information, 2024, v. 38, n. 4, p. 937
- By:
- Publication type:
- Article
The Benefits of Sustaining High Factor VIII Levels in People With Hemophilia A.
- Published in:
- American Journal of Managed Care, 2025, p. S15, doi. 10.37765/ajmc.2025.89703
- By:
- Publication type:
- Article
A Unified Set of Patient-inspired Health Concepts for Chronic Obstructive Pulmonary Disease: A North Star for Understanding Treatment Benefit.
- Published in:
- Annals of the American Thoracic Society, 2025, v. 22, n. 3, p. 317, doi. 10.1513/AnnalsATS.202408-864IP
- By:
- Publication type:
- Article
Drug Development in Inflammatory Bowel Diseases: What Is Next?
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 190, doi. 10.3390/ph18020190
- By:
- Publication type:
- Article
New Serious Safety Warnings for Targeted Anticancer Agents After Their Initial FDA Approval.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 584, doi. 10.3390/cancers17040584
- By:
- Publication type:
- Article
Is the pendulum slowly starting to swing back?
- Published in:
- Cardio-Oncology, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40959-025-00321-w
- By:
- Publication type:
- Article
Comparison of Tissue-Engineered Dermis with Micronized Adipose Tissue and Artificial Dermis for Facial Reconstruction Following Skin Cancer Resection.
- Published in:
- Bioengineering (Basel), 2025, v. 12, n. 2, p. 145, doi. 10.3390/bioengineering12020145
- By:
- Publication type:
- Article
Technical Note.
- Published in:
- Journal of Case Studies, 2024, v. 42, n. 2, p. 66
- Publication type:
- Article
Novel (Q)SAR models for prediction of reversible and time-dependent inhibition of cytochrome P450 enzymes.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1451164
- By:
- Publication type:
- Article
Rare disease challenges and potential actions in the Middle East.
- Published in:
- International Journal for Equity in Health, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12939-025-02388-4
- By:
- Publication type:
- Article
Regulatory efforts to address the access gap for foreign new drugs in China: the priority review program and related policies.
- Published in:
- Global Health Research & Policy, 2025, v. 10, n. 1, p. 1, doi. 10.1186/s41256-024-00396-5
- By:
- Publication type:
- Article
Pharmaceutical regulations in Iraq: from medicine approval to post- marketing.
- Published in:
- Eastern Mediterranean Health Journal, 2021, v. 27, n. 10, p. 1007, doi. 10.26719/emhj.21.025
- By:
- Publication type:
- Article
An overview of the Hepatitis C control plan in Qatar.
- Published in:
- Eastern Mediterranean Health Journal, 2019, v. 25, n. 5, p. 362, doi. 10.26719/emhj.18.046
- By:
- Publication type:
- Article
The Multidrug-Resistant Gram-negative Superbug Threat Requires Intelligent Use of the Last Weapon.
- Published in:
- Malaysian Journal of Medical Sciences, 2015, v. 22, n. 5, p. 1
- By:
- Publication type:
- Article
Approval times and the safety of new pharmaceuticals.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Correction: Ritlecitinib in severe alopecia areata: a profile of its use.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Zavegepant nasal spray in the acute treatment of migraine: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 11, doi. 10.1007/s40267-024-01130-4
- By:
- Publication type:
- Article
New therapies for primary biliary cholangitis usher in a personalised approach to treatment.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 28, doi. 10.1007/s40267-024-01129-x
- By:
- Publication type:
- Article
Lotilaner ophthalmic solution 0.25% in Demodex blepharitis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 11, p. 444, doi. 10.1007/s40267-024-01111-7
- By:
- Publication type:
- Article
Lecanemab in Alzheimer's disease: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 10, p. 393, doi. 10.1007/s40267-024-01108-2
- By:
- Publication type:
- Article
Sodium oxybate extended-release suspension (LUMRYZ<sup>™</sup>) in narcolepsy: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 10, p. 385, doi. 10.1007/s40267-024-01105-5
- By:
- Publication type:
- Article
Ritlecitinib in severe alopecia areata: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 9, p. 341, doi. 10.1007/s40267-024-01086-5
- By:
- Publication type:
- Article
Zuranolone in postpartum depression: a profile of its use in the USA.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 6, p. 195, doi. 10.1007/s40267-024-01074-9
- By:
- Publication type:
- Article
Aim to alleviate alopecia areata with newly available agents.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 5, p. 181, doi. 10.1007/s40267-024-01069-6
- By:
- Publication type:
- Article
Sparsentan in immunoglobulin A nephropathy: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 3, p. 101, doi. 10.1007/s40267-024-01058-9
- By:
- Publication type:
- Article
Manage vitiligo with a personalised approach: consider old and new treatments.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 421, doi. 10.1007/s40267-023-01032-x
- By:
- Publication type:
- Article
Ublituximab in relapsing forms of multiple sclerosis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 11, p. 365, doi. 10.1007/s40267-023-01030-z
- By:
- Publication type:
- Article
Manage idiopathic hypersomnia with a combination of non-pharmacological and pharmacological treatments.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 11, p. 378, doi. 10.1007/s40267-023-01028-7
- By:
- Publication type:
- Article
Desidustat in anaemia in patients with chronic kidney disease: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 8, p. 279, doi. 10.1007/s40267-023-01012-1
- By:
- Publication type:
- Article
Dextromethorphan/bupropion in major depressive disorder: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 8, p. 270, doi. 10.1007/s40267-023-01009-w
- By:
- Publication type:
- Article
Oteseconazole in recurrent vulvovaginal candidiasis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 8, p. 263, doi. 10.1007/s40267-023-01008-x
- By:
- Publication type:
- Article
Mavacamten in obstructive hypertrophic cardiomyopathy: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 7, p. 223, doi. 10.1007/s40267-023-01003-2
- By:
- Publication type:
- Article
Nivolumab/relatlimab in advanced melanoma: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 3, p. 89, doi. 10.1007/s40267-023-00980-8
- By:
- Publication type:
- Article
Mitotane in adrenocortical carcinoma: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 12, p. 508, doi. 10.1007/s40267-022-00958-y
- By:
- Publication type:
- Article
Difelikefalin in pruritus associated with chronic kidney disease: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 10, p. 423, doi. 10.1007/s40267-022-00945-3
- By:
- Publication type:
- Article
Aducanumab: a review of the first approved amyloid-targeting antibody for Alzheimer's disease.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 10, p. 443, doi. 10.1007/s40267-022-00944-4
- By:
- Publication type:
- Article
Vosoritide in achondroplasia: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 10, p. 417, doi. 10.1007/s40267-022-00942-6
- By:
- Publication type:
- Article